Todd Meyerrose

Todd Meyerrose is a seasoned entrepreneur, investor, and advisor specializing in biotechnology and healthcare ventures leveraging cutting-edge technology to expedite the discovery process and introduce innovative products to the market.

With a strong academic background, Todd pursued his education rigorously, obtaining a PhD in Molecular Cell Biology from Washington University School of Medicine in St. Louis, a PhD in Craniofacial Biology and Development from the University of Southern California, and a BS in Biology from the University of Kentucky.

Throughout his professional journey, Todd has been involved in a myriad of prominent organizations, holding various roles such as founder, investor, advisor, and co-founder. Some of the notable organizations in which he has been actively engaged include Osmind, FaunaBio, RxLive, Mend Bio, Rondo Therapeutics, Navio, Pragma Bio, ixlayer, Mediphage Bioceuticals Inc., Halo Tech Software, MedAnswers, Boost Biomes, Genome Medical, Inc., Lexent Bio, BioMed Ventures, Auransa Inc., Stanford University, Hibernation Therapeutics, and PathDrugomics.